Jagsonpal Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 76.35 | 62.88 | 45.97 |
| Operating Expense | 58.41 | 54.49 | 40.82 |
| Net Profit | 11.46 | 5.33 | 3.55 |
| Net Profit Margin | 15.01 | 8.48 | 7.72 |
| Earning Per Share | 4.29 | 1.94 | 1.31 |
| EBIDTA | 16.71 | 8.21 | 5.17 |
| Effective Tax Rate | 14.94 | 18.93 | 19.38 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 76.35 |
| Operating Expense | 58.41 |
| Net Profit | 11.46 |
| Net Profit Margin | 15.01 |
| Earning Per Share | 4.29 |
| EBIDTA | 16.71 |
| Effective Tax Rate | 14.94 |
Invest in Jagsonpal Pharmaceuticals Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 208.70 | 236.71 | 217.58 |
| Operating Expenses Annual | 185.64 | 202.56 | 192.56 |
| Operating Profit Annual | 32.35 | 36.43 | 28.45 |
| Interest Annual | 0.81 | 0.41 | 0.29 |
| Depreciation | 1.66 | 1.18 | 1.53 |
| Net Profit Annual | 22.46 | 26.72 | 18.86 |
| Tax Annual | 7.41 | 8.09 | 7.79 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 208.70 |
| Operating Expenses Annual | 185.64 |
| Operating Profit Annual | 32.35 |
| Interest Annual | 0.81 |
| Depreciation | 1.66 |
| Net Profit Annual | 22.46 |
| Tax Annual | 7.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 11.05 | 22.53 | 58.94 |
| Cash Flow from Operations | 35.17 | 46.66 | 6.91 |
| Cash Flow from Investing | -24.55 | -57.67 | -25.78 |
| Cash Flow from Financing | -8.91 | -0.46 | -17.55 |
| Cash Flow at the End | 12.76 | 11.05 | 22.53 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 11.05 |
| Cash Flow from Operations | 35.17 |
| Cash Flow from Investing | -24.55 |
| Cash Flow from Financing | -8.91 |
| Cash Flow at the End | 12.76 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 15.50 | 15.39 | 13.08 |
| PBIT Margin (%) | 14.70 | 14.87 | 12.38 |
| PBT Margin (%) | -3.45 | -21.42 | -30.32 |
| Net PROFIT Margin (%) | 10.76 | 11.29 | 8.67 |
| Return On Networth / Equity (%) | 12.97 | 18.32 | 15.28 |
| Return On Networth /Employed (%) | 16.89 | 23.48 | 21.14 |
| Return On Assets (%) | 12.38 | 17.84 | 14.39 |
| Total Debt / Equity (X) | 0.04 | 0.02 | 0.03 |
| Asset Turnover Ratio (%) | 1.15 | 1.58 | 1.66 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 15.50 |
| PBIT Margin (%) | 14.70 |
| PBT Margin (%) | -3.45 |
| Net PROFIT Margin (%) | 10.76 |
| Return On Networth / Equity (%) | 12.97 |
| Return On Networth /Employed (%) | 16.89 |
| Return On Assets (%) | 12.38 |
| Total Debt / Equity (X) | 0.04 |
| Asset Turnover Ratio (%) | 1.15 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 9.30 | 24.28 | 22.60 |
| Total Current Assets Annual | 199.25 | 164.56 | 109.08 |
| Non Current Assets Annual | 17.82 | 30.39 | 55.14 |
| Total Shareholders Funds Annual | 187.40 | 158.89 | 132.76 |
| Total Assets Annual | 217.08 | 194.95 | 164.23 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 9.30 |
| Total Current Assets Annual | 199.25 |
| Non Current Assets Annual | 17.82 |
| Total Shareholders Funds Annual | 187.40 |
| Total Assets Annual | 217.08 |
No Data Availabe
